德克斯特罗米多芬-布普 (Auvelity) 用于治疗严重抑郁症

相关实验视频

Updated: Jul 12, 2025

04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.6K

Brian McCarthy¹, Hannah Bunn², Morgan Santalucia²

¹Mood Treatment Center, Winston-Salem, NC, USA.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

|October 20, 2023

概括

德克斯特罗米多芬-布普 (Auvelity) 提供了一种快速起作用和耐受性良好的治疗主要抑郁障碍. 临床试验显示显著的症状减少,高缓解率,并持续有效性随着时间的推移.

科学领域:

神经科学是一个神经科学.
精神病学是一个精神病学.
药理学药理学是指药理学的学科.

背景情况:

大型抑郁症 (MDD) 是全球发病率和死亡率的主要原因之一.
现有的抑郁症治疗方法往往有延迟的疗效,不完整的反应和不良影响.
需要有效,快速起作用,耐受性良好的抑郁症疗法.

研究的目的:

审查德克斯特罗米多芬-布普 (Auvelity) 对成年MDD的安全性和疗效.
评估其新的作用机制和临床试验结果.

主要方法:

对MDD中使用德克斯特罗梅索芬-布普罗的第二期和第三期临床试验的审查.
蒙哥马利-阿斯伯格抑郁评分表 (MADRS) 评分,缓解和反应率的分析.
评估安全性和耐受性数据,包括不良事件.

主要成果:

与安慰剂和布普罗单独治疗相比,德克斯特罗米多芬-布普罗在MADRS得分上显示出显著的降低.
在治疗开始后两周内观察到抗抑郁作用.
与对照组相比,使用德克斯特罗米多芬-布普罗的患者获得了更高的缓解和响应率.
治疗一般耐受良好,并有轻度至中度的不良反应.
长期研究显示了持续的疗效,缓解率接近70%,响应率超过80%.

结论:

德克斯特罗米多芬-布洛是一种有效的,快速起作用的治疗方案,用于重度抑郁症.
它提供了有利的安全性和耐受性.
这种药物在患有MDD的患者中表现出持续的疗效和高缓解率和反应.

关键词:

这就是安赫多尼亚 (Anhedonia).抗抑郁药是一种抗抑郁药.药物组合药物组合是一种药物组合.胺基氨酸 (ketamine) 是一种可以治疗结果的结果.

相关概念视频

01:23

Antidepressant Drugs: MAOIs and Other Agents

254

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

254

01:25

Antidepressant Drugs: Overview

524

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

524

01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

410

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...

410

01:27

Depressive Disorders: MDD and Dysthymia

138

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

138

01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

183

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

183